MLAB (Mesa Laboratories) Risk Assessment


MLAB Mesa Laboratories Inc MLAB
77 GF Score
Price $105.39
GF Value $116.15
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Mesa Laboratories Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Mesa Laboratories is: Moderate Risk: Sensitive, better choose undervalued stock.

Mesa Laboratories  (NAS:MLAB) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Mesa Laboratories Risk Assessment Related Terms

MLAB vs AERG, USBC, MVIS: Risk Assessment Comparison

For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mesa Laboratories Risk Assessment vs Hardware Industry

For the Hardware industry and Technology sector, Mesa Laboratories's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Mesa Laboratories's Risk Assessment falls into.


MLAB
77GF Score
Mesa Laboratories Inc MLAB
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mesa Laboratories (MLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued. The current stock price of $105.39 is trading 9.3% below its estimated GF Value™ of $116.15. GuruFocus considers Mesa Laboratories to be Fairly Valued.

Key valuation signals for MLAB:

  • Risk Assessment:
  • GF Value™: $116.15 vs. price of $105.39 (9.3% below fair value)
  • GF Score™: 77/100 with 8 warning signs

No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mesa Laboratories Business Description

Address 12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score

Get the complete analysis for MLAB

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$105.39
Price
$116.15
GF Value